home / stock / vbiv / vbiv short
Short Information | VBI Vaccines Inc. (NASDAQ:VBIV)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 872,752 |
Total Actual Volume | 3,435,447 |
Short Trends | |
---|---|
Cover Days | 12 |
Short Days | 1 |
No Change Days | 7 |
Averages | |
---|---|
Average Short Volume | 43,638 |
Average Short Percentage | 29.60% |
Is there a VBIV Short Squeeze or Breakout about to happen?
See the VBIV Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $0.7 | $0.711 | $0.7799 | $0.6849 | 383,429 | 76,990 | 20.08% |
07-01-2024 | $0.6683 | $0.692 | $0.697 | $0.6601 | 76,561 | 10,299 | 13.45% |
06-28-2024 | $0.66 | $0.66 | $0.67 | $0.61 | 601,286 | 52,178 | 8.68% |
06-27-2024 | $0.658 | $0.65 | $0.658 | $0.6325 | 211,788 | 42,263 | 19.96% |
06-26-2024 | $0.65 | $0.64 | $0.652 | $0.6302 | 329,239 | 75,331 | 22.88% |
06-25-2024 | $0.6275 | $0.645 | $0.645 | $0.6203 | 421,838 | 148,325 | 35.16% |
06-24-2024 | $0.6 | $0.6186 | $0.625 | $0.6 | 89,700 | 27,755 | 30.94% |
06-21-2024 | $0.59 | $0.598 | $0.6036 | $0.57131 | 144,229 | 36,271 | 25.15% |
06-20-2024 | $0.5976 | $0.5862 | $0.60703 | $0.5712 | 103,006 | 21,750 | 21.12% |
06-18-2024 | $0.5801 | $0.5954 | $0.621899 | $0.5801 | 130,909 | 30,274 | 23.13% |
06-17-2024 | $0.59 | $0.5735 | $0.601101 | $0.562 | 111,817 | 39,366 | 35.21% |
06-14-2024 | $0.59 | $0.595 | $0.606899 | $0.5899 | 44,368 | 16,137 | 36.37% |
06-13-2024 | $0.6 | $0.586201 | $0.62 | $0.57 | 118,402 | 34,553 | 29.18% |
06-12-2024 | $0.61 | $0.603 | $0.63 | $0.6001 | 189,728 | 70,660 | 37.24% |
06-11-2024 | $0.585 | $0.61 | $0.61 | $0.58 | 69,051 | 23,513 | 34.05% |
06-10-2024 | $0.59 | $0.585 | $0.61 | $0.57 | 126,407 | 46,108 | 36.48% |
06-07-2024 | $0.604 | $0.5964 | $0.62 | $0.57 | 45,490 | 14,505 | 31.89% |
06-06-2024 | $0.63 | $0.609 | $0.63 | $0.6 | 74,174 | 26,223 | 35.35% |
06-05-2024 | $0.595 | $0.6001 | $0.62 | $0.5801 | 108,603 | 55,585 | 51.18% |
06-04-2024 | $0.6075 | $0.5951 | $0.615 | $0.5801 | 55,422 | 24,666 | 44.51% |
News, Short Squeeze, Breakout and More Instantly...
Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response (PR) and two stable disease (SD) observations have occurred as of May 15, 2024 The partial response, which demonstrated a 67% reduction in tumor size vs. baseline, wa...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the ongoing randomized, controlled Phase 2b study of VBI-1901, the Company’s ca...
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 105% year-over-year in the first quarter of 2024 compared to the first quarter of 2023 Initial encouraging tumor response data from randomized Phase 2b study of VBI-1901 in recurrent glioblastoma (GBM) anno...